beta-lactams has been researched along with Bronchiolitis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Eigenmann, P | 1 |
Brun-Buisson, C; Caserio-Schönemann, C; Cheysson, F; Guillemot, D; Le Fouler, L; Opatowski, L; Pontais, I; Watier, L | 1 |
Boersma, WG; van der Eerden, MM | 1 |
3 other study(ies) available for beta-lactams and Bronchiolitis
Article | Year |
---|---|
Risk factors for bronchiolitis and asthma, and COVID-19 symptoms in young children.
Topics: Asthma; beta-Lactams; Bronchiolitis; Child; Child, Preschool; COVID-19; Humans; Hypersensitivity; Risk Factors; SARS-CoV-2 | 2021 |
Outpatient antibiotic use attributable to viral acute lower respiratory tract infections during the cold season in France, 2010-2017.
Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Bronchiolitis; Bronchitis; Child, Preschool; Emergency Service, Hospital; France; Humans; Inappropriate Prescribing; Influenza, Human; Macrolides; Outpatients; Pneumonia; Practice Patterns, Physicians'; Respiratory Tract Infections; Seasons; Virus Diseases | 2021 |
Impact of macrolide therapy on mortality in severe sepsis caused by pneumonia.
Topics: Anti-Bacterial Agents; beta-Lactams; Bronchiolitis; Community-Acquired Infections; Critical Care; Cystic Fibrosis; Humans; Inflammation; Macrolides; Pneumonia; Randomized Controlled Trials as Topic; Sepsis; Treatment Outcome | 2009 |